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Human lifestyle inmostmodern and developing societies has
dramatically changed over past decades. Physical inactivity
along with unrestricted access to calorie dense foods has
established an “obesogenic” environment and contributed to
a serious epidemic of obesity and type 2 diabetes (T2D),
associated with increased morbidity and mortality. In 2005
a population-based study conducted by Reichmuth et al. of
University of Wisconsin with a cross-sectional and longi-
tudinal analysis identified that among 1387 participants the
odds ratio for T2D with an apnea-hypopnea index (AHI) >
15 versus an AHI < 5 was 2.30 (1.28–4.11; 𝑝 < 0.01) after
adjustment for age, sex, and body habitus [1].Therefore it has
been assumed that intermittent hypoxic periods associated
with obstructive sleep apnea (OSA) may play a pathogenic
role in inducing insulin resistance and T2D. At organ/tissue
levels, in 2007–2009 Ye and colleagues first proposed a
central role played by adipose tissue hypoxia resulting from
adipocyte expansion in promoting chronic inflammation,
adiponectin reduction, adipocyte dysfunction, and death
in obese individuals [2, 3]. This group of researchers later
identified the mediator roles played by hypoxia inducible
factor 1𝛼 (HIF-1𝛼) [4] and other hypoxia-triggered signaling
mechanisms that may promote free fatty acid release and
inhibit glucose uptake in adipocytes by inhibition of the
insulin-signaling pathway and induction of cell death [5].
Furthermore, at the whole-body level, systemic noctur-
nal intermittent hypoxia was shown to be associated with
increased risk of developing T2D in middle-aged men [6].
Most recently, another elegant study examined 601 partici-
pants who were originally enrolled into the Wisconsin Sleep
Cohort around 18 years ago and found that hypoxia may be a
stimulus for cardiac hypertrophy in individuals withOSA [7].
This study showed that the decade-long occurrence of OSA
was associated independently with decreasing left ventricular
systolic function andwith reduced right ventricular function.
Echocardiographic measures of adverse cardiac remodeling
were strongly associated with OSA but were confounded
by obesity. Nevertheless, it remains elusive how systemic
versus local tissue hypoxia affects the key pathophysiological
processes of obesity and T2D, such as metabolic imbalance,
inflammation, dysglycemia, and insulin resistance. Con-
versely, the changes resulting from T2D may also alter the
adaptation ability or resistance of an organ against tissue
injuries caused by hypoxia or ischemia and in turn affect
the progression and outcome of many chronic diseases. For
example, the studies from our and other groups revealed that
obese and/or T2D animals were refractory to ischemic post-
conditioning, a promising cardioprotective modality against
myocardial infarction [8–10].
Under this context, our primary goal for guest-editing
this special issue is to provide a platform for insightful dis-
cussions and exchanges of divergent ideas concerning sys-
temic and local hypoxia as trigger or treatment (in some
cases) of adipose tissue dysfunction and other organ injuries
in obesity and T2D, to invite and showcase the cutting edge
original research articles and reviews focusing on the impact
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of continuous or intermittent systemic hypoxia (e.g., altitude
training and OSA), as well as localized tissue hypoxia (in
adipose and other types of tissues), on the pathogenesis,
progression, and possible novel treatments of obesity and
T2D. New revelation of brown adipose tissue activity in adult
humans has stimulated vigorous investigations on how it can
serve as a prevention and treatment target for obesity and
insulin resistance; a particular emphasis is to analyze the
role of brown adipose tissue in whole-body energy home-
ostasis and substrate metabolism under normal and hypoxic
conditions.
Out of a dozen of submitted manuscripts in response to
our call-for-papers, seven papers authored by 35 biomed-
ical researchers or physician scientists from China, Hong
Kong, Slovenia, United Kingdom, and United States have
been selected through a rigorous peer-review process and
finally included in this special issue. The following are some
highlights of these accepted works.
Most relevant to the main theme, the review article by
R. W. A. Mackenzie and P. Watt has provided insights at the
molecular and whole-body levels on the mechanisms sur-
rounding glucose disposal and insulin resistance with sys-
temic exposure to chronic hypoxia. These authors thought-
fully discussed the complex and paradoxically opposing
effects of hypoxia on the development of insulin resistance.
On the one hand, hypoxia may induce insulin resistance
either via the direct action on insulin receptor substrate and
protein kinase B/Akt or indirectly through adipose tissue
expansion and systemic inflammation. Yet hypoxia may
also promote glucose transport via insulin-dependent mech-
anisms largely reliant on AMP-activated protein kinase
(AMPK) and hypoxic exposure could improve glucose con-
trol in T2D. The authors’ provocative conclusion is that
hypoxia may decrease insulin signaling but may not induce
whole-body insulin resistance.
Another focus of this special issue has been on adipose
tissue, a biologically active organ that is vital for lipid storage,
energy homeostasis, and whole-body insulin sensitivity [11].
Three articles have addressed this important topic. P. Zhou
et al. explored the effects of inhibitor of DNA binding 2 gene
(Id2) deficiency in the regulation of core body temperature
over the circadian cycle and the impact of Id2 deficiency on
genes involved in insulin signaling and adipogenesis in
brown adipose tissue. Their findings lend support for Id2
as an important coordinator of energy homeostasis includ-
ing insulin signaling, adipogenic programing, and ther-
moregulation. In addition, at the adipocyte level, J. Sun et
al. demonstrated that free fatty acids activated the renin-
angiotensin system in mouse 3T3-L1 adipocytes through a
nuclear factor-kappa B-dependent signaling pathway, which
shed light on the molecular basis for a vicious cycle between
obesity and adipose tissue inflammation. Importantly, the
authors identified the signaling pathways of activation of
local adipose RAS in preadipocyte. They found that free
fatty acid (palmitic acid, PA) could upregulate the expression
of angiotensinogen and angiotensin type 1 receptor and
also stimulate the secretion of angiotensin II in 3T3-L1
adipocytes. Moreover, the activation of renin-angiotensin
system in 3T3-L1 adipocytes was inhibited when Toll-like
receptor 4 (TLR4) signaling pathway was blocked by TLR4
inhibitor or NF-𝜅B inhibitor, suggesting involvement of the
PA/TLR4/NF-𝜅B signaling pathway in regulating the local
renin-angiotensin system in adipose tissue. More relevant
to the hypoxia-related problems, H. H. Chowdhury et al.
provided evidence that hypoxia alters expression of dipep-
tidyl peptidase 4 (DPP4) and induces developmental remod-
eling of human preadipocytes. The authors indicated that
hypoxia strongly inhibits DPP4 protease activity and insulin-
mediated increase in DPP4 suggesting that DPP4 represents
an important marker for early detection of insulin resistance.
Two articles in this special issue targeted myocardial
ischemia-reperfusion injury, an important pathological con-
dition complicated by obesity and/or T2D. L. Pang et al. thor-
oughly analyzed the less understood prostaglandin E recep-
tor subtype 4 signaling in the heart, which could pro-
foundly impact ischemia-reperfusion injury and cardiac
hypertrophic response in T2D. Metformin, a first-line med-
ication for the treatment of T2D, was reported to be pro-
tective against cardiac ischemia-perfusion injury [12]. In
this special issue, M. Hu et al. provided further evidence
formetformin-induced cytoprotection against hypoxia-reox-
ygenation injury in H9C2 rat cardiomyocytes under normal
and hyperglycemic conditions. The authors demonstrated
that the protection may be via an intracellular signaling
mechanism involving AMPK and JNK (Jun NH(2)-terminal
kinase). Given this commonly prescribed medication, an
understanding of its underlying mechanisms is vital both for
clinicians and for patients.
Finally, a review by D. Grinnan et al. presented a frame-
work with epidemiological, clinical, biochemical, and molec-
ular evidence to support a role for diabetes mellitus in the
pathogenesis of pulmonary arterial hypertension.The review,
in this issue, is both timely and significant in trumpeting
the need for future robust research to confirm an association
between diabetes mellitus and pulmonary hypertension, to
demonstrate diabetes as a disease modifier of pulmonary
arterial hypertension, and to investigate the outcome of
glycemic control on pulmonary hypertension. From an edi-
torial perspective, this review underscores the need for future
investigations in endothelial dysfunction in pulmonary arte-
rial hypertension in patients with diabetes who have comor-
bid conditions of chronic obstructive pulmonary disease
and OSA, since hypoxia experienced in these patient groups
has an added vasoconstrictive stress on the pulmonary vas-
culature [13]. Notably, the interaction between intermittent
hypoxia and obesity/T2D was not covered in the current
issue.This topic deserves greater attention. Future studies are
warranted to investigate this often controversial area, that is, a
pathogenic role played by OSA in inducing insulin resistance
and T2D in humans [1, 14] versus the exposure to moderate
intermittent hypoxia that may serve as a therapeutic means
for reducing obesity and T2D [15].
We would like to thank all contributors to this special
issue for their participation. We believe that the works pre-
sented in this special issue may instigate innovative research
and development of new therapeutic drugs for the future
treatment of diabetes and diabetes complications. There
remain many questions to be answered regarding the role of
Journal of Diabetes Research 3
hypoxia in the pathogenesis and treatment target of obesity
and T2D.
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